Showing results (41-50 of 467) with videos related to
Sort By:
Pageof 47
European Journal of Biochemistry|April 2, 1998
Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypesJ Vergote, J L Moretti, E G de Vries, et al.Cancer Metastasis Reviews|February 8, 2002
Death receptor ligands, in particular TRAIL, to overcome drug resistanceS de Jong, T Timmer, F J Heijenbrok, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damageJ Marrink, D T Sleijfer, E G de Vries, et al.Anticancer Research|July 23, 1998
Mutual interactions between p53 and growth factors in cancerJ G Asschert, E Vellenga, S De Jong, et al.European Journal of Cancer & Clinical Oncology|January 1, 1987
In vitro chemosensitivity of human lung cancer for vindesineE G De Vries, C Meijer, N H Mulder, et al.Anticancer Research|August 23, 2000
Chemo-immunotherapy of ovarian cancer in a murine tumour modelA H Klimp, E G De Vries, G L Scherphof, et al.Blut|March 1, 1982
Combination chemotherapy for acute lymphocytic leukaemia in 25 adultsE G de Vries, N H Mulder, B Houwen, et al.Cancer Treatment Reviews|March 1, 1995
High-dose chemotherapy regimens for solid tumorsE van der Wall, J H Beijnen, S RodenhuisMedical Oncology and Tumor Pharmacotherapy|January 1, 1985
Tube feeding of cancer patients treated with chemotherapyE G de Vries, W M Kreumer, D L Schippers, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1987
Twice weekly vindesine, a phase II study in lung cancerP E Postmus, N H Mulder, D L Schipper, et al.Pageof 47